5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: Should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma

Cancer Chemotherapy and Pharmacology

Volumn 58, Issue 2, 2006, Pages 276-278

  Formica, V ^a   Leary, A ^a   Cunningham, D ^a   Chua, Y J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

5 Fluorouracil; Capecitabine; Encephalopathy

Indexed keywords

CAPECITABINE; CARBOPLATIN; FLUOROPYRIMIDINE; FLUOROURACIL; GEMCITABINE; OXALIPLATIN; RALTITREXED;

ADULT; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; BLOOD BRAIN BARRIER; BRAIN DISEASE; BREAST CANCER; CANCER ADJUVANT THERAPY; CASE REPORT; COLON ADENOCARCINOMA; COLORECTAL CANCER; COMA; DRUG DOSE REDUCTION; DRUG INDICATION; DRUG PENETRATION; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; LEUKOPENIA; NEUROTOXICITY; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; THROMBOCYTOPENIA; URINARY TRACT INFECTION;

ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASES; COMA; DEOXYCYTIDINE; FLUOROURACIL; HUMANS;

EID: 33646485390     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-005-0159-4     Document Type: Article

References (14)

1. Anderson CM, Xiong W, Young JD, Cass CE, Parkinson FE (1996) Demonstration of the existence of mRNAs encoding N1/cif and N2/cit sodium/ nucleoside cotransporters in rat brain. Mol Brain Res 42:358-361
2. Bourke RS, West CR, Chheda G, Tower DB (1973) Kinetics of entry and distribution of 5-fluorouracil in cerebrospinal fluid and brain following intravenous injection in a primate. Cancer Res 33:1735-1746
3. Cassidy J, Twelves C, Van Cutsem E, Hoff P, Bajetta E, Boyer M, Bugat R, Burger U, Garin A, Graeven U, McKendric J, Maroun J, Marshall J, Osterwalder B, Perez-Manga G, Rosso R, Rougier P, Schilsky RL, Capecitabine Colorectal Cancer Study Group (2002) First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol 13:566-575
4. Couch LS, Groteluschen DL, Stewart JA, Mulkerin DL (2003) Capecitabine-related neurotoxicity presenting as trismus. Clin Colorectal Cancer 3:121-123
5. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC, Harris AL (1995) Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 176:183-190
6. Mata JF, Garcia-Manteiga JM, Lostao MP, Fernandez-Veledo S, Guillen-Gomez E, Larrayoz IM, Lloberas J, Casado FJ, Pastor-Anglada M (2001) Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5′-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug. Mol Pharmacol 59:1542-1548
7. Niemann B, Rochlitz C, Herrmann R, Pless M (2004) Toxic encephalopathy induced by capecitabine. Oncology 66:331-335
8. [No authors listed] (1999) Case records of the Massachusetts General Hospital, weekly clinicopathological exercises. Case 24-1999. Neurologic disorder in a 65-year-old man after treatment of colon cancer. N Engl J Med 341:512-519
9. Phuphanich S, Jacobs M, Spiers A (1994) Response of recurrent brain metastases in malignant melanoma to 5-fluorouracil and interferon-alpha therapy. J Neuroimaging 4:114-116
10. Roche Xeloda (capecitabine) data sheet
11. Shehata N, Pater A, Tang SC (1999) Prolonged severe 5-fluorouracil- associated neurotoxicity in a patient with dihydropyrimidine dehydrogenase deficiency. Cancer Invest 17:201-205
12. Takimoto CH, Lu ZH, Zhang R, Liang MD, Larson LV, Cantilena LR Jr, Grem JL, Allegra CJ, Diasio RB, Chu E (1996) Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency. Clin Cancer Res 2:477-481
13. Tamai I, Tsuji A (2000) Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci 89:1371-1388
14. Wang ML, Yung WK, Royce ME, Schomer DF, Theriault RL (2001) Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer. Am J Clin Oncol 24:421-424